[Second chance for renal artery denervation]

Area of Science:

• Cardiovascular Medicine
• Interventional Cardiology
• Nephrology

Background:

• Resistant arterial hypertension poses a significant clinical challenge.
• Endovascular therapies are evolving for managing difficult-to-treat hypertension.
• Renal sympathetic nerve activity plays a role in blood pressure regulation.

Purpose of the Study:

• To review and critically assess contemporary randomized studies on radiofrequency denervation of renal arteries.
• To evaluate the advantages and disadvantages of this endovascular treatment.
• To identify potential optimizations for the management of resistant arterial hypertension.

Main Methods:

• Systematic review of randomized controlled trials.
• Critical appraisal of study methodologies and outcomes.
• Analysis of efficacy, safety, and patient selection criteria.

Main Results:

• Radiofrequency denervation shows variable efficacy in reducing blood pressure in resistant hypertension.
• Potential benefits include improved hemodynamic parameters and reduced medication burden.
• Adverse events are generally infrequent but require careful monitoring.

Conclusions:

• Radiofrequency denervation is a promising endovascular option for select patients with resistant hypertension.
• Further research is needed to refine patient selection and optimize procedural techniques.
• Long-term outcomes and cost-effectiveness require continued investigation.